Trialect

Active

Drug Discovery Against Parasitic Diseases

Instituto Universitario de Enfermedades Tropicales Y Salud Pública de Canarias /UNIVERSIDAD DE LA LAGUNA

Our group is currentl working on drug doscovery against parasitic protozoa diseases. Interested people could get trained in in vitro and in vivo assays as well as PCD evaluation. Moreover other techniques and methods are used day by day in our institution.

Main Areas of Interest

Free-Living Amoebae
Leishmania spp.
Trypanosoma spp.

Specialties

Microbiology

Molecular Biology

Techniques You Will Learn

Colorimetric Assays
Image-Based Cytometry
Real-Time PCR
In Vitro and In Vivo Assays
BSL-2 and BSL-3 Facilities

Curriculum

The Principal Investigator (PI), Jacob Lorenzo Morales, has dedicated over a decade to studying free-living amoebae (FLA), with a primary focus on the Acanthamoeba genus. His research aims to identify potential therapeutic targets using siRNA to develop novel treatments against this pathogen. His work extends to other FLAs, such as Balamuthia mandrillaris, Sappinia, and Naegleria fowleri, all of which can cause fatal encephalitis in humans and animals.

In recent years, Dr. Morales has also contributed to the diagnosis of SARS-CoV-2 and the development of novel antiviral devices and agents. With over 15 years of experience in diagnosing and treating tropical diseases and emerging pathogens, Dr. Morales boasts an h-index of 41, with more than 6800 citations, including over 3900 citations since 2019. He has published over 250 articles in JCR-indexed journals within Tropical Medicine, Parasitology, and Protozoology, and has presented more than 300 communications at national and international conferences.

Dr. Morales has organized international congresses and workshops on free-living amoebae and has reviewed international grants and over 250 manuscripts for journals like PLOS Neglected Tropical Diseases and Antimicrobial Agents and Chemotherapy. His accolades include the "Joven Canarias 2013" individual prize, the second prize in the 2015 "Premios Talento y Compromiso de Cajasiete," and the 2020 Internationalization award from the University of La Laguna. He played a significant role in the Acanthamoeba genome project, with the data published in Genome Biology in 2013, cited over 300 times. Dr. Morales has supervised 21 PhD theses and 20 Master's theses.

Accommodation

The city of San Cristóbal of La Laguna presents a wide range of accommodations from shared flats to students halls of residence and private housing.

Fees and Program Logistics

This program has the following durations available:

Duration	Fee
2 weeks	$750.00
6 weeks	$1,625.00
12 weeks	$2,875.00

This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.

Who Can Apply

Anyone interested in drug discovery or emerging parasitic protozoa

Host Details

Host Name: Jacob Lorenzo-Morales

Affiliation: Instituto Universitario de Enfermedades Tropicales Y Salud Pública de Canarias /UNIVERSIDAD DE LA LAGUNA

Address: Avenida Astrofisico Fco. Sánchez SN 38203 La Laguna, Tenerife, Islas Canarias

Website URL: https://portalciencia.ull.es/unidades/5508/detalle

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.